Quarterly report [Sections 13 or 15(d)]

Statements of Operations and Comprehensive Income (Loss) (Unaudited)

v3.26.1
Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 1,607 $ 2,171
General and administrative 6,830 5,818
Total operating expenses 8,437 7,989
Loss from operations (8,437) (7,989)
Other income (expenses):    
Interest income 394 226
Interest expense (15)
Change in fair value of warrant liability (4,780) 8,348
Total other income (expenses) (4,386) 8,559
Net income (loss) (12,823) 570
Other comprehensive loss:    
Unrealized loss on marketable securities, net (1)
Net comprehensive income (loss) (12,824) 570
Net comprehensive income (loss) attributable to common stockholders, basic (12,824) 510
Net comprehensive loss attributable to common stockholders, diluted $ (12,824) $ (6,214)
Net comprehensive income (loss) per share    
Basic (in Dollars per share) $ (0.54) $ 0.04
Diluted (in Dollars per share) $ (0.54) $ (0.5)
Weighted-average shares outstanding used in computing net comprehensive income (loss) per share:    
Basic (in Shares) 23,908,153 11,681,881
Diluted (in Shares) 23,908,153 12,383,477